Handwriting Movement Abnormalities in Symptomatic and Premanifest Huntington's Disease.

Huntington's disease handwriting kinematics

Journal

Movement disorders clinical practice
ISSN: 2330-1619
Titre abrégé: Mov Disord Clin Pract
Pays: United States
ID NLM: 101630279

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 27 02 2019
revised: 01 07 2019
accepted: 08 07 2019
entrez: 21 9 2019
pubmed: 21 9 2019
medline: 21 9 2019
Statut: epublish

Résumé

Kinematic measures of handwriting movements are sensitive to mild subclinical motor abnormalities stemming from a wide range of disorders involving the basal ganglia including Huntington's disease (HD). Prior research has not investigated handwriting movements in at-risk individuals in the premanifest stage of HD. The purpose of this study was to examine whether handwriting movement abnormalities are present prior to clinically manifest chorea in HD. A total of 38 symptomatic HD, 30 gene-positive premanifest, and 25 healthy control participants completed handwriting tasks consisting of circles, loops, sentences, and spirals with a noninking pen on a digitizing tablet. Multiple measures of pen stroke kinematics and pressure were measured along with the cognitive and motor status of each participant. Burden of pathology and CAG × age product scores were obtained from each participant with HD. Participants with HD exhibited significantly longer and more variable stroke durations, decreased handwriting smoothness, and increased and more variable pen pressures when compared with the healthy controls. We found significant positive associations between stroke duration and both burden of pathology and CAG × age product. Results from a discriminant function analysis revealed a 7-factor model that distinguished premanifest from healthy controls with 85% accuracy. Factors in the model included greater variability in stroke amplitude, velocity and pen pressure, higher levels of pen pressure, longer stroke durations, and lower velocities for combinations of handwritten circles, sentences, and spirals. These findings support the clinical utility of dynamic measures of handwriting kinematics as a potential early behavioral biomarker in HD.

Sections du résumé

BACKGROUND BACKGROUND
Kinematic measures of handwriting movements are sensitive to mild subclinical motor abnormalities stemming from a wide range of disorders involving the basal ganglia including Huntington's disease (HD). Prior research has not investigated handwriting movements in at-risk individuals in the premanifest stage of HD.
OBJECTIVES OBJECTIVE
The purpose of this study was to examine whether handwriting movement abnormalities are present prior to clinically manifest chorea in HD.
METHODS METHODS
A total of 38 symptomatic HD, 30 gene-positive premanifest, and 25 healthy control participants completed handwriting tasks consisting of circles, loops, sentences, and spirals with a noninking pen on a digitizing tablet. Multiple measures of pen stroke kinematics and pressure were measured along with the cognitive and motor status of each participant. Burden of pathology and CAG × age product scores were obtained from each participant with HD.
RESULTS RESULTS
Participants with HD exhibited significantly longer and more variable stroke durations, decreased handwriting smoothness, and increased and more variable pen pressures when compared with the healthy controls. We found significant positive associations between stroke duration and both burden of pathology and CAG × age product. Results from a discriminant function analysis revealed a 7-factor model that distinguished premanifest from healthy controls with 85% accuracy. Factors in the model included greater variability in stroke amplitude, velocity and pen pressure, higher levels of pen pressure, longer stroke durations, and lower velocities for combinations of handwritten circles, sentences, and spirals.
CONCLUSIONS CONCLUSIONS
These findings support the clinical utility of dynamic measures of handwriting kinematics as a potential early behavioral biomarker in HD.

Identifiants

pubmed: 31538093
doi: 10.1002/mdc3.12824
pii: MDC312824
pmc: PMC6749811
doi:

Types de publication

Journal Article

Langues

eng

Pagination

586-592

Références

J Neurol Sci. 1999 Jan 1;162(1):106-7
pubmed: 10064180
Neurology. 2001 Sep 11;57(5):920-4
pubmed: 11552034
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Hum Mov Sci. 2009 Oct;28(5):633-42
pubmed: 19692133
Psychiatry Res. 2010 May 15;177(1-2):77-83
pubmed: 20381875
Mov Disord. 2011 Oct;26(12):2267-73
pubmed: 21661053
J Forensic Sci. 2014 Jul;59(4):1020-4
pubmed: 24673648
J Clin Psychopharmacol. 2015 Apr;35(2):168-74
pubmed: 25679121
Neuropsychologia. 1995 Mar;33(3):365-9
pubmed: 7792003
Mov Disord. 1994 Sep;9(5):521-30
pubmed: 7990847
Mov Disord. 1996 Mar;11(2):136-42
pubmed: 8684382
Ann Neurol. 1997 May;41(5):689-92
pubmed: 9153534
Exp Neurol. 1997 Jul;146(1):159-70
pubmed: 9225749
J Int Neuropsychol Soc. 1999 Jan;5(1):20-5
pubmed: 9989020

Auteurs

Michael Caligiuri (M)

Department of Psychiatry University of California San Diego La Jolla California USA.

Chase Snell (C)

Department of Neurosciences University of California San Diego La Jolla California USA.

Sungmee Park (S)

Department of Neurosciences University of California San Diego La Jolla California USA.

Jody Corey-Bloom (J)

Department of Neurosciences University of California San Diego La Jolla California USA.

Classifications MeSH